At 7:00 on March 18 (CST), an online medical discussion was convened among experts from Yale University and The First Affiliated Hospital, Zhejiang University School of Medicine and fruitful results were achieved. Almost 100 experts attended the meeting to discuss methods on how to defeat the common enemy of mankind – COVID-19.

As of 19:00 on March 17 (EST), confirmed cases in the USA stood at 6,331 and death cases stood at 105. There were 1,646 people cured and discharged from hospital. Medical staff from Yale University expressed their eagerness to learn from the experience that FAHZU had gained in its two-month-fight against COVID-19. The meeting lasted for more than 1 hour.

“What’s the key point of your treatment protocol?”

“Could you please share with us your experience in the treatment of critically ill patients?”

“Is mother-to-child transmission possible?”

“What is the standard of patients’ being sent to ICU?”

“How about your medical team in Wuhan?”

“How to make sure that medical staff are not infected?”

Medical workers from Emergency, ICU, Anesthesiology, General Surgery, Obstetrics and Rehabilitation Medicine asked many questions. Their rigorous attitude towards science and eagerness to learn about COVID-19 prevention and treatment experience greatly impressed Prof. Liang Tingbo, President of FAHZU. Doctors from Infectious Diseases, Respiratory Medicine, Laboratory Medicine, Pharmacy and ICU answered them one by one.

Prof. Liang briefly introduced the COVID-19 prevention and treatment strategies at FAHZU. He also mentioned that on Feb. 6th, a COVID-19 patient had a Cesarean and successfully delivered a baby. Samples collected from umbilical cord blood, placenta, amniotic fluid and the sputum of the baby were all tested negative for SARS-CoV-2. There is no evidence for mother-to-child transmission. Prof. Liang said the Handbook of COVID-19 Prevention and Treatment would be released later that morning to share our experience in the field of management, diagnosis and treatment as well as nursing. Most of the questions are answered in the Handbook. The answers gained recognition from the counterparts in Yale.

Prof. Liang stated, “FAHZU is willing to share with everyone all the results we had. We also welcome our counterparts all over the globe to update and improve this treatment plan.”